Jerome H Kim

Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144.

Jaranit Kaewkungwal, Joseph Chiu, Nelson L Michael, 2012, The Lancet. Infectious diseases.

Immune-correlates analysis of an HIV-1 vaccine efficacy trial.

Guido Ferrari, Youyi Fong, Jaranit Kaewkungwal, 2012, The New England journal of medicine.

COMPASS identifies T-cell subsets correlated with clinical outcomes

Greg Finak, Raphael Gottardo, Jaranit Kaewkungwal, 2015, Nature Biotechnology.

The Thai Phase III Trial (RV144) Vaccine Regimen Induces T Cell Responses That Preferentially Target Epitopes within the V2 Region of HIV-1 Envelope

Jaranit Kaewkungwal, Nelson L Michael, Supachai Rerks-Ngarm, 2012, The Journal of Immunology.

Statistical interpretation of the RV144 HIV vaccine efficacy trial in Thailand: a case study for statistical issues in efficacy trials.

Peter B Gilbert, Max Essex, James O Berger, 2011, The Journal of infectious diseases.

Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2.

Guido Ferrari, Jaranit Kaewkungwal, Xiaozhi Lu, 2013, Immunity.